STOCK TITAN

HYPERFINE Financials

HYPR
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows HYPERFINE (HYPR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HYPR FY2025

Improving gross economics are being offset by a development-stage expense base that still relies on outside funding.

From FY2023 to FY2025, gross margin improved from 43.1% to 49.8%, showing the product is no longer being sold at a loss. Yet FY2025 R&D spend of $17.5M still exceeded revenue of $13.6M, which helps explain why lower burn has not translated into self-funded operations.

FY2025 operating cash outflow of -$27.9M was smaller than the -$35.6M net loss, so reported earnings were not being flattered by non-cash accounting. Because capital spending was just $1.2M, the gap between operating cash flow and free cash flow stayed narrow, making this an expense-funded rather than equipment-funded burn story.

The balance sheet still looks liquid on the surface, with $35.1M of cash and a 4.3x current ratio, so near-term bills are not the immediate constraint. But financing inflow of $27.5M in FY2025 nearly matched free cash burn of -$29.1M, showing that recent balance-sheet stability came from new capital rather than from the business funding itself.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&D Intensity Revenue Progress Burn Trend Balance Sheet 55 / 100
Financial Health Score 55/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of HYPERFINE's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
48
R&D Intensity
68
Revenue Progress
62
Burn Trend
60
Balance Sheet
90
Altman Z-Score Distress
-5.09

HYPERFINE scores -5.09, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($104.2M) relative to total liabilities ($14.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/7

HYPERFINE passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality
0.79x

For every $1 of reported earnings, HYPERFINE generates $0.79 in operating cash flow (-$27.9M OCF vs -$35.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$13.6M
YoY+5.2%
5Y CAGR+115.2%

HYPERFINE generated $13.6M in revenue in fiscal year 2025. This represents an increase of 5.2% from the prior year.

EBITDA
-$36.0M
YoY+14.7%

HYPERFINE's EBITDA was -$36.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 14.7% from the prior year.

Net Income
-$35.6M
YoY+12.6%

HYPERFINE reported -$35.6M in net income in fiscal year 2025. This represents an increase of 12.6% from the prior year.

EPS (Diluted)
$-0.43
YoY+23.2%

HYPERFINE earned $-0.43 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$29.1M
YoY+25.6%

HYPERFINE generated -$29.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 25.6% from the prior year.

Cash & Debt
$35.1M
YoY-6.8%
5Y CAGR-11.0%

HYPERFINE held $35.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
49.8%
YoY+4.1pp
5Y CAGR+212.0pp

HYPERFINE's gross margin was 49.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.1 percentage points from the prior year.

Operating Margin
-273.4%
YoY+61.9pp
5Y CAGR+7716.7pp

HYPERFINE's operating margin was -273.4% in fiscal year 2025, reflecting core business profitability. This is up 61.9 percentage points from the prior year.

Net Margin
-262.3%
YoY+53.6pp
5Y CAGR+7706.1pp

HYPERFINE's net profit margin was -262.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 53.6 percentage points from the prior year.

Return on Equity
-86.8%
YoY-3.7pp

HYPERFINE's ROE was -86.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.7 percentage points from the prior year.

Capital Allocation

R&D Spending
$17.5M
YoY-22.4%
5Y CAGR+3.6%

HYPERFINE invested $17.5M in research and development in fiscal year 2025. This represents a decrease of 22.4% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$1.2M
YoY+209.4%
5Y CAGR-5.4%

HYPERFINE invested $1.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 209.4% from the prior year.

HYPR Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $3.9M-26.3% $5.3M+54.0% $3.4M+27.5% $2.7M+26.2% $2.1M-7.9% $2.3M-36.3% $3.6M+0.3% $3.6M
Cost of Revenue $1.9M-26.0% $2.6M+63.6% $1.6M+16.2% $1.4M+9.1% $1.3M-16.1% $1.5M-13.8% $1.7M-5.1% $1.8M
Gross Profit $2.0M-26.5% $2.7M+45.8% $1.8M+39.2% $1.3M+50.4% $883K+6.9% $826K-56.7% $1.9M+5.8% $1.8M
R&D Expenses $3.8M+0.5% $3.8M-5.5% $4.0M-10.9% $4.5M-9.8% $5.0M-1.3% $5.1M-13.0% $5.9M-1.6% $6.0M
SG&A Expenses $4.1M+2.4% $4.0M-2.8% $4.2M+7.6% $3.9M-8.3% $4.2M+1.8% $4.1M-8.4% $4.5M+2.0% $4.4M
Operating Income -$8.6M-11.6% -$7.7M+14.0% -$8.9M+7.0% -$9.6M+12.0% -$10.9M-1.3% -$10.8M+1.8% -$11.0M-1.1% -$10.8M
Interest Expense $83K N/A N/A N/A $0 N/A N/A N/A
Income Tax $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$8.6M-45.9% -$5.9M+46.3% -$11.0M-19.4% -$9.2M+2.0% -$9.4M+9.4% -$10.4M-0.6% -$10.3M-1.7% -$10.2M
EPS (Diluted) $-0.09 N/A $-0.14-16.7% $-0.120.0% $-0.12 N/A $-0.140.0% $-0.14

HYPR Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $60.3M+9.2% $55.3M+33.1% $41.5M-8.2% $45.2M-15.3% $53.4M-9.4% $58.9M-15.1% $69.4M-9.4% $76.6M
Current Assets $56.0M+10.1% $50.9M+38.0% $36.9M-8.0% $40.1M-17.2% $48.4M-9.9% $53.7M-16.2% $64.1M-9.8% $71.0M
Cash & Equivalents $40.8M+16.2% $35.1M+62.7% $21.6M-15.2% $25.4M-23.2% $33.1M-12.1% $37.6M-17.7% $45.8M-14.9% $53.8M
Inventory $6.3M-10.8% $7.1M+21.4% $5.8M+19.6% $4.9M+5.2% $4.6M-20.5% $5.8M-17.2% $7.0M-5.6% $7.5M
Accounts Receivable $3.8M-27.8% $5.3M+7.5% $4.9M-3.4% $5.1M-5.1% $5.3M-10.5% $6.0M-12.4% $6.8M+26.7% $5.4M
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $26.0M+82.2% $14.3M-2.6% $14.6M+44.8% $10.1M-1.5% $10.3M+4.1% $9.9M-10.9% $11.1M+12.3% $9.8M
Current Liabilities $10.2M-13.5% $11.7M+15.4% $10.2M+27.3% $8.0M+0.1% $8.0M-8.6% $8.7M-12.4% $10.0M+13.4% $8.8M
Long-Term Debt $13.1M $0 N/A N/A N/A N/A N/A N/A
Total Equity $34.4M-16.2% $41.0M+52.6% $26.9M-23.5% $35.1M-18.5% $43.1M-12.1% $49.0M-15.9% $58.3M-12.6% $66.8M
Retained Earnings -$338.6M-2.6% -$330.0M-1.8% -$324.1M-3.5% -$313.1M-3.0% -$303.9M-3.2% -$294.4M-3.7% -$284.1M-3.8% -$273.7M

HYPR Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$9.0M-73.0% -$5.2M+6.7% -$5.6M+29.4% -$7.9M+14.5% -$9.2M-10.7% -$8.4M+1.9% -$8.5M+9.2% -$9.4M
Capital Expenditures $242K+284.1% $63K-51.5% $130K-75.0% $520K+10.2% $472K+5800.0% $8K-95.0% $159K+123.9% $71K
Free Cash Flow -$9.3M-75.5% -$5.3M+7.7% -$5.7M+32.2% -$8.4M+13.3% -$9.7M-16.2% -$8.4M+3.6% -$8.7M+8.2% -$9.5M
Investing Cash Flow -$242K-284.1% -$63K+51.5% -$130K+75.0% -$520K-10.2% -$472K-5800.0% -$8K+95.0% -$159K-123.9% -$71K
Financing Cash Flow $14.5M-24.9% $19.3M+791.0% $2.2M+356.5% $474K-91.5% $5.6M+10237.0% $54K-93.7% $851K+1342.4% $59K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

HYPR Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 50.7%-0.2pp 50.9%-2.9pp 53.8%+4.5pp 49.3%+7.9pp 41.3%+5.7pp 35.6%-16.8pp 52.4%+2.7pp 49.7%
Operating Margin -219.3%-74.4pp -144.9%+114.7pp -259.5%+96.4pp -355.9%+154.2pp -510.1%-46.3pp -463.8%-162.9pp -300.9%-2.2pp -298.7%
Net Margin -220.9%-109.2pp -111.7%+208.9pp -320.6%+21.6pp -342.2%+98.5pp -440.7%+6.9pp -447.6%-164.2pp -283.4%-3.7pp -279.7%
Return on Equity -25.1%-10.7pp -14.4%+26.6pp -41.0%-14.8pp -26.3%-4.4pp -21.8%-0.7pp -21.2%-3.5pp -17.7%-2.5pp -15.2%
Return on Assets -14.3%-3.6pp -10.7%+15.8pp -26.5%-6.2pp -20.4%-2.7pp -17.6%0.0pp -17.6%-2.8pp -14.9%-1.6pp -13.3%
Current Ratio 5.52+1.2 4.34+0.7 3.63-1.4 5.02-1.0 6.07-0.1 6.15-0.3 6.44-1.6 8.08
Debt-to-Equity 0.38+0.4 0.00-0.5 0.54+0.3 0.29+0.0 0.24+0.0 0.20+0.0 0.19+0.0 0.15
FCF Margin -237.0%-137.4pp -99.6%+66.6pp -166.2%+146.5pp -312.7%+142.2pp -454.9%-94.5pp -360.4%-122.2pp -238.2%+22.2pp -260.4%

Similar Companies

Frequently Asked Questions

HYPERFINE (HYPR) reported $13.6M in total revenue for fiscal year 2025. This represents a 5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

HYPERFINE (HYPR) revenue grew by 5.2% year-over-year, from $12.9M to $13.6M in fiscal year 2025.

No, HYPERFINE (HYPR) reported a net income of -$35.6M in fiscal year 2025, with a net profit margin of -262.3%.

HYPERFINE (HYPR) reported diluted earnings per share of $-0.43 for fiscal year 2025. This represents a 23.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

HYPERFINE (HYPR) had EBITDA of -$36.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, HYPERFINE (HYPR) had $35.1M in cash and equivalents against $0 in long-term debt.

HYPERFINE (HYPR) had a gross margin of 49.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

HYPERFINE (HYPR) had an operating margin of -273.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

HYPERFINE (HYPR) had a net profit margin of -262.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

HYPERFINE (HYPR) has a return on equity of -86.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

HYPERFINE (HYPR) generated -$29.1M in free cash flow during fiscal year 2025. This represents a 25.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

HYPERFINE (HYPR) generated -$27.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

HYPERFINE (HYPR) had $55.3M in total assets as of fiscal year 2025, including both current and long-term assets.

HYPERFINE (HYPR) invested $1.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

HYPERFINE (HYPR) invested $17.5M in research and development during fiscal year 2025.

HYPERFINE (HYPR) had a current ratio of 4.34 as of fiscal year 2025, which is generally considered healthy.

HYPERFINE (HYPR) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

HYPERFINE (HYPR) had a return on assets of -64.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, HYPERFINE (HYPR) had $35.1M in cash against an annual operating cash burn of $27.9M. This gives an estimated cash runway of approximately 15 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

HYPERFINE (HYPR) has an Altman Z-Score of -5.09, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

HYPERFINE (HYPR) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

HYPERFINE (HYPR) has an earnings quality ratio of 0.79x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

HYPERFINE (HYPR) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top